Nexstim Plc: Share subscriptions based on stock options 2020A
Company Announcement, Helsinki, 3 November 2023 at 9:30 AM (EET)
Nexstim Plc: Share subscriptions based on stock options 2020A
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that between 1 April and 2 October 2023, a total of 1,000 Nexstim Plc’s new shares has been subscribed for with the company's stock options 2020A. For subscriptions made with the stock options 2020A, the entire subscription price of EUR 2,000.00 will be entered in the reserve for invested unrestricted equity.
After the trade registration the total amount of shares is 6,765,562.
The shares subscribed for under the stock options 2020A will be registered in the Trade Register on 6 November 2023, as of which date the new shares will establish shareholder rights.
The shares will be traded in the Nasdaq Helsinki Plc’s First North Growth Market Finland marketplace as an additional lot with the company’s old shares as of 7 November 2023.
The terms and conditions of stock option programs with additional information are available on the company's website at https://www.nexstim.com/investors/.
Further information is available on the website www.nexstim.com, or by contacting:
Leena Niemistö, Chair of Board of Directors
+358 9 2727 170
leena.niemisto@nexstim.com
The Company’s Certified Advisor is Erik Penser Bank.
About Nexstim Plc
Nexstim is a Finnish, globally operating growth-oriented medical technology company. Our mission is to enable personalized and effective diagnostics and therapies for challenging brain diseases and disorders.
Nexstim has developed a world-leading non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
Nexstim’s Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS System 5 is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.
Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBS 6 system is CE marked for the treatment of major depression and chronic neuropathic pain.
Nexstim shares are listed on Nasdaq First North Growth Market Finland.
For more information, please visit www.nexstim.com
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Eimskip: Transaction in relation to a share buy-back program11.12.2023 09:30:00 CET | Press release
In week 49 2023 Eimskip purchased 132,000 of its own shares, at a purchase price of ISK 59,367,000 as further stipulated below: DateTimeNo. of sharesShare pricePurchase price4.12.202311:3233,000453.5014,965,5005.12.202311:1833,000449.5014,833,5006.12.202313:4633,000448.0014,784,0008.12.202311:4933,000448.0014,784,000Total132,00059,367,000 The trade is in accordance with Eimskip‘s buy-back program as published on Nasdaq Iceland on 10 October 2023. Eimskip held 2,979,320 shares prior to the notified transactions, and holds 3,111,320 after them, or the equivalent of 1.85% of issued shares in the company. Under current buy-back program Eimskip has purchased a total of 1,386,000 shares in the company, corresponding to 64.47 % of the maximum amount of shares to be purchased under this program. Total purchase price is ISK 636,916,500 corresponding to 63.69 % of the maximum ISK amount of the buy-back program. Buy-back under the program will amount to a maximum of 2,150,000 shares and the marke
Aktietilbagekøb i Sparekassen Sjælland-Fyn – transaktioner i uge 4911.12.2023 09:29:29 CET | pressemeddelelse
Selskabsmeddelelse nr. 40/2023 Holbæk, den 11. december 2023 Aktietilbagekøb i Sparekassen Sjælland-Fyn – transaktioner i uge 49 Sparekassen Sjælland-Fyn A/S (”Sparekassen”) offentliggjorde den 10. august 2023 et tilbagekøbsprogram på 100 mio. kr. Aktietilbagekøbsprogrammet startede den 10. august 2023 og vil være afsluttet senest den 8. februar 2024. Aktietilbagekøbsprogrammet sker med henblik på nedsættelse af aktiekapitalen i Sparekassen og gennemføres efter bestemmelserne i Europa-Parlamentets og Rådets forordning (EU) nr. 596/2014 af 16. april 2014 og EU Kommissionens delegerede forordning (EU) 2016/1052 af 8. marts 2016, samlet kaldet Safe Harbour-reglerne. Under aktietilbagekøbsprogrammet er gennemført følgende transaktioner: Antal aktierGennemsnitlig købskursTransaktionsværdiAkkumuleret seneste meddelelse 217.777 42.668.776,564. december 2023 5. december 2023 6. december 2023 7. december 2023 8. december 20232.400 2.400 2.300 2.200 2.200197,78 199,46 201,81 198,90 198,69474.672
Aktietilbagekøb11.12.2023 09:28:50 CET | pressemeddelelse
Nørresundby, den 11. december 2023 Selskabsmeddelelse nr. 22/2023 Bestyrelsen i RTX har, jf. selskabsmeddelelse nr. 20/2023 af 30. november 2023, besluttet at iværksætte et aktietilbagekøbsprogram i overensstemmelse med bestemmelserne i artikel 5 i Europa-Parlamentets og Rådets forordning (EU) nr. 596/2014 af 16. april 2014 (MAR) og Kommissionens delegerede forordning (EU) 2016/1052, også kaldet "Safe Harbor"-forordningen. Under programmet vil RTX tilbagekøbe aktier for et beløb på op til DKK 20 mio. i perioden fra 1. december 2023 til 30. september 2024. Følgende transaktioner er foretaget under programmet i perioden nedenfor: Antal aktierGennemsnitlig købsprisTransaktionsværdi i DKKRTX-aktier før programmets start 258.528 Akkumuleret andel i programmet, seneste udmelding 1. december 2023 3.000 73,14 219.420 4. december 2023 3.000 73,97 221.910 5. december 2023 3.100 71,09 220.379 6. december 2023 3.200 71,01 227.232 7. december 2023 3.000 70,3 210.900 8. december 2023 2.201 70,29 154
Share repurchase programme11.12.2023 09:28:50 CET | Press release
Noerresundby, Denmark, 11 December 2023 Announcement no. 22/2023 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated 30 November 2023, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission’s delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbor" regulation. Under the programme RTX will buy back shares for an amount up to DKK 20 million in the period from 1 December 2023 to 30 September 2024. The following transactions have been made under the programme in the period below: Number of SharesAverage Purchase PriceTransaction value in DKKRTX shares prior to initiation of the programme 258.528 Accumulated share in the programme, latest announcement 1. december 2023 3.000 73,14 219.420 4. december 2023 3.000 73,97 221.910 5. december 2023 3.100 71,09 220.379 6. december 2023 3.200 71,01 227.
Preliminary data on early redemptions (prepayments)11.12.2023 09:25:35 CET | Press release
To Nasdaq Copenhagen A/S 11 December 2023 Announcement no. 113/2023 Preliminary data on early redemptions (prepayments) Pursuant to S. 24 of the Capital Markets Act, we hereby publish preliminary data on early redemptions (prepayments) in bonds issued by Jyske Realkredit. Please find the data in the attached file. The information will also be available on Jyske Realkredit’s web site at jyskerealkredit.com. For further information about format of data and content of the file we refer to the web site of Nasdaq at www.nasdaqomxnordic.com. Questions may be addressed to Christian Bech-Ravn, Head of Investor Relations, tel. (+45) 89 89 92 25. Yours sincerely Jyske Realkredit Please observe that the Danish version of this announcement prevails Attachment 113_FortIndf20231208JYK